2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol

C42H84N2O11 — CID 143687742

IUPAC2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol
SMILESCC.CC.CC1CC(N(C)C(C)C)CC(O)O1.CNC(=O)COC1C(C)C(O)[C@](C)(O)COC(=O)C(C)[C@@H](O[C@H]2CC(C)CC(C)O2)CC[C@](C)(O)C[C@H]1C
InChIInChI=1S/C28H51NO9.C10H21NO2.2C2H6/c1-16-11-18(3)37-23(12-16)38-21-9-10-27(6,33)13-17(2)24(35-14-22(30)29-8)20(5)25(31)28(7,34)15-36-26(32)19(21)4;1-7(2)11(4)9-5-8(3)13-10(12)6-9;2*1-2/h16-21,23-25,31,33-34H,9-15H2,1-8H3,(H,29,30);7-10,12H,5-6H2,1-4H3;2*1-2H3/t16?,17-,18?,19?,20?,21+,23+,24?,25?,27+,28-;;;/m1.../s1
InChIKeyQVVLGXCMEKRYCD-USPVHFPPSA-N
MW793.14 g/mol
LogP5.43
Rot. Bonds7

About 2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol

2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol (PubChem CID 143687742) has the molecular formula C42H84N2O11 and a molecular weight of 793.14 g/mol. Its IUPAC name is 2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol.

Molecular Properties

Compound Name2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol
PubChem CID143687742
Molecular FormulaC42H84N2O11
Molecular Weight793.14 g/mol
Exact Mass792.61
IUPAC Name2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol
SMILESCC.CC.CC1CC(N(C)C(C)C)CC(O)O1.CNC(=O)COC1C(C)C(O)[C@](C)(O)COC(=O)C(C)[C@@H](O[C@H]2CC(C)CC(C)O2)CC[C@](C)(O)C[C@H]1C
InChIInChI=1S/C28H51NO9.C10H21NO2.2C2H6/c1-16-11-18(3)37-23(12-16)38-21-9-10-27(6,33)13-17(2)24(35-14-22(30)29-8)20(5)25(31)28(7,34)15-36-26(32)19(21)4;1-7(2)11(4)9-5-8(3)13-10(12)6-9;2*1-2/h16-21,23-25,31,33-34H,9-15H2,1-8H3,(H,29,30);7-10,12H,5-6H2,1-4H3;2*1-2H3/t16?,17-,18?,19?,20?,21+,23+,24?,25?,27+,28-;;;/m1.../s1
InChIKeyQVVLGXCMEKRYCD-USPVHFPPSA-N
XLogP5.43
TPSA176.48 Ų
H-Bond Donors5
H-Bond Acceptors12
Rotatable Bonds7
Heavy Atoms55
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500793.14
LogP ≤ 55.43
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1012

Analyze 2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol?
The IUPAC name of 2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol (CID 143687742) is 2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol.
What is the SMILES notation for 2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol?
The canonical SMILES for 2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol is CC.CC.CC1CC(N(C)C(C)C)CC(O)O1.CNC(=O)COC1C(C)C(O)[C@](C)(O)COC(=O)C(C)[C@@H](O[C@H]2CC(C)CC(C)O2)CC[C@](C)(O)C[C@H]1C.
What is the InChIKey of 2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol?
The InChIKey is QVVLGXCMEKRYCD-USPVHFPPSA-N. The full InChI is InChI=1S/C28H51NO9.C10H21NO2.2C2H6/c1-16-11-18(3)37-23(12-16)38-21-9-10-27(6,33)13-17(2)24(35-14-22(30)29-8)20(5)25(31)28(7,34)15-36-26(32)19(21)4;1-7(2)11(4)9-5-8(3)13-10(12)6-9;2*1-2/h16-21,23-25,31,33-34H,9-15H2,1-8H3,(H,29,30);7-10,12H,5-6H2,1-4H3;2*1-2H3/t16?,17-,18?,19?,20?,21+,23+,24?,25?,27+,28-;;;/m1.../s1.
What are the key properties of 2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol?
2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol has a molecular weight of 793.14 g/mol, XLogP of 5.43, 7 rotatable bonds, 5 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[(3R,7R,9S,12S)-12-[(2S)-4,6-dimethyloxan-2-yl]oxy-3,4,9-trihydroxy-3,5,7,9,13-pentamethyl-14-oxo-oxacyclotetradec-6-yl]oxy]-N-methylacetamide;ethane;6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-ol is sourced from PubChem (CID 143687742), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).